Medscape

Transdermal Analgesia Equivalent to IV Morphine

March 16, 2004 — An investigational fentanyl patient-controlled analgesia (PCA) transdermal system was found to provide postsurgical pain control equivalent to that of a standard intravenous (IV) ...
FierceBiotech

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain -In this open-label study, the Sufentanil ...
EurekAlert!

Transdermal patch as effective as intravenous pump for post-op pain control

Use of a transdermal patch to deliver pain medication was found to be equivalent to medication delivered by an intravenous pump for controlling pain following surgery, according to a study in the ...
Monthly Prescribing Reference

Gabapentin Doesn’t Cut Use of Morphine Post-Knee Arthroplasty

(HealthDay News) – The addition of gabapentin to patient-controlled analgesia (PCA) protocol does not reduce morphine consumption, pain, or opioid-related side effects in patients undergoing total ...
Science Daily

Patient controlled analgesia in the emergency department is effective

Two studies are the first to track the effectiveness of patient-controlled pain relief (PCA - patient-controlled analgesia) in patients from the Emergency Department to the ward. The studies show that ...
ascopubs.org

Optimizing Intravenous Patient-Controlled Analgesia for Cancer Pain: A Randomized Controlled Trial on Adjusted Background Infusion Rates

Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
FiercePharma

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab® PCA System vs. IV PCA Morphine for Post-Operative Pain

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab® PCA System vs. IV PCA Morphine for Post-Operative Pain -In this open-label study, the ...